View
2
Download
0
Category
Preview:
Citation preview
07/03/11
1
Biological markers for the diagnosis and the Biological markers for the diagnosis and the prognosis of preterm prematureprognosis of preterm premature
rupture of membranesrupture of membranes
F. GoffinetF. GoffinetPortPort--Royal maternity, University ParisRoyal maternity, University Paris--DescartesDescartesINSERM U953 Epidemiological Research Unit on INSERM U953 Epidemiological Research Unit on
Perinatal Health and Women’s and Children HealthPerinatal Health and Women’s and Children Health
1
2nd IFCC2nd IFCC--Ortho Clinical Diagnostics ConferenceOrtho Clinical Diagnostics Conference25th february 201125th february 2011
PPROM : implication for perinatal healthPPROM : implication for perinatal health
ManagementManagement
PPROMPPROMPreterm Premature Rupture Of MembranesPreterm Premature Rupture Of Membranes
ManagementManagementPositive impact on perinatal healthPositive impact on perinatal healthBut Invasive treatmentBut Invasive treatmentConsequences of false positive and false negative resultsConsequences of false positive and false negative results
Effective diagnosisEffective diagnosisClinicalClinical
2
BiologicalBiological
Prognosis in cases of PPROMPrognosis in cases of PPROMPreterm delivery or infection ?Preterm delivery or infection ?Many biomarkers studied Many biomarkers studied Biomarkers used currentlyBiomarkers used currently
07/03/11
2
PPROM : frequency and impact on PPROM : frequency and impact on prematurityprematurity
••PPROM: 3 % of pregnanciesPPROM: 3 % of pregnancies
––20 to 40 % of the PROM20 to 40 % of the PROM––30 to 40% of preterm deliveries 30 to 40% of preterm deliveries Mercer BM et al. Am J Obstet Gynecol 2000
3
Am J Obstet Gynecol 2000
Goldenberg RL Goldenberg RL et al. Lancet 2008et al. Lancet 2008
PPROM, PPROM, laborlabor and infectionand infection
4
07/03/11
3
PPROM, PPROM, laborlabor and infectionand infection
5
inflammation
preterm delivery preterm delivery infection infection –– inflammationinflammation
Main cause of Main cause of preterm birthpreterm birth
Hervé R. et al. J Immunol. 2008Schmitz T. et al. J Immunol. 2007
Chorionic Chorionic cellscells
ProteinsProteinsreleasedreleased
6
Rupture of Rupture of membranesmembranes
Myometrial Myometrial ContractionContraction
CervicalCervicalmaturationmaturation
Preterm birthPreterm birth
Preterm Preterm MarkersMarkers
07/03/11
4
•• Maternal complications: Maternal complications: chorioamnionitis (2chorioamnionitis (2--8%), endometritis8%), endometritis
PPROMPPROMconsequencesconsequences
•• Perinatal complications = preterm birthPerinatal complications = preterm birthPerinatal mortalityPerinatal mortalityShort term complications: Enterocolitis, bronchodysplasia, Short term complications: Enterocolitis, bronchodysplasia, periventricular leukomalacia,periventricular leukomalacia,
7
Long term outcome : cerebral palsy, sensorial deficit, Long term outcome : cerebral palsy, sensorial deficit, mental retardationmental retardation
Infection = additional pejorative factorInfection = additional pejorative factor
Management in cases of PPROM (1)Management in cases of PPROM (1)no signs of infectionno signs of infection
before 32before 32--34 Weeks34 Weeks after 32after 32--34 weeks34 weeks
HospitalisationHospitalisationAntibioticsAntibiotics
Maternal transferMaternal transfer
HospitalisationHospitalisationAntibioticsAntibiotics
Maternal transferMaternal transfer
8
Tocolysis 24Tocolysis 24--48 hours48 hoursCorticosteroidsCorticosteroids
Search for infectionSearch for infection
Search for infectionSearch for infection
Induction of labor Induction of labor at 34at 34--36 weeks36 weeks
07/03/11
5
Management in cases of PPROM (2)Management in cases of PPROM (2)use of a high CRP in decisionsuse of a high CRP in decisions
ClinicalClinicalCh i i itiCh i i iti
High CRPHigh CRPChorioamnionitisChorioamnionitis
11--2 % at admission2 % at admissionBefore 30Before 30--34 34
WksWksAfter 30After 30--34 34
WksWks
9
« delivery»« delivery»
No tocolysisNo tocolysisTo gain time…To gain time…
deliverydelivery
History taking and clinicalHistory taking and clinical
Diagnostic methods and prognostic criteria in the case of premature rupture of the membranes
Verspyck E et Al. J Gynecol Obstet Biol Reprod. 1999 Verspyck E et Al. J Gynecol Obstet Biol Reprod. 1999
Diagnosis of PPROM : clinicalDiagnosis of PPROM : clinical
80% 80%
History taking and clinical History taking and clinical examination are often sufficientexamination are often sufficient
10
Sterile speculum examination: Sterile speculum examination: leakage of amniotic fluid leakage of amniotic fluid
from cervical os continued from cervical os continued and expanded by the and expanded by the
mobilization mobilization
07/03/11
6
Biomarkers: Quality requiredBiomarkers: Quality required
Strictly specific molecule of the AF Strictly specific molecule of the AF Present at all gestational agesPresent at all gestational agesNO «NO « GOLD STANDARDGOLD STANDARD » »
To confirm the diagnosis of To confirm the diagnosis of rupture of membranesrupture of membranes
Present at all gestational ages Present at all gestational ages Slow degradation Slow degradation Easily detectable at low concentrationEasily detectable at low concentrationThe test should be rapid and available The test should be rapid and available 24 h a day24 h a day
•• prevent false positive resultsprevent false positive resultsC t i ti (bl d i l li id)C t i ti (bl d i l li id)
No perfect No perfect biomarkersbiomarkers
11
•• Contamination (blood, seminal liquid)Contamination (blood, seminal liquid)
•• prevent false negative resultsprevent false negative results•• Rupture of membranes very early in the pregnancyRupture of membranes very early in the pregnancy•• Disappearance of the markerDisappearance of the marker•• Concentration too lowConcentration too low
N G ld t d d f di i f PPROMN G ld t d d f di i f PPROM
Verspyck E, Landman T, Marpeau L J Gynecol Obstet Biol Reprod 1999
Published results Published results methodological drawbacksmethodological drawbacks
Very few studies compared diagnostic value of different testsVery few studies compared diagnostic value of different tests
CutCut--offs to define an abnormal test could be different in the studiesoffs to define an abnormal test could be different in the studies
No Gold standard for diagnosis of PPROM No Gold standard for diagnosis of PPROM
12
Comparison groups : No rupture of membranes versus cases with clear Comparison groups : No rupture of membranes versus cases with clear liquid flow liquid flow Target population : suspicion of PPROM (intermittent or no leakage of Target population : suspicion of PPROM (intermittent or no leakage of fluid) fluid) -- cases in which clinical diagnosis is not evidentcases in which clinical diagnosis is not evident
07/03/11
7
Localization of the biomarkers usedLocalization of the biomarkers used
13
amniotic fluid crystallization testing amniotic fluid crystallization testing –– fern testfern test
SensSens SpecSpec PPVPPV NPVNPV
Fern testFern test
42%42% 76%76%
14
--Gibbs, 1982Gibbs, 1982 42%42% 76%76% -- --
Contamination with cervical mucus (false positive result)Contamination with cervical mucus (false positive result)Learning required (microscope)Learning required (microscope)
subjectivesubjective
07/03/11
8
NbNb SensSens SpecSpec VPPVPP VPNVPN
A lot of biomarkers studiedA lot of biomarkers studied
DAO (DAO (DiAmineDiAmine Oxydase)Oxydase)
‐‐ GaucherandGaucherand, 1997, 1997 100100 83,783,7 100100 100100 8989
‐‐ De Meeus, 1997De Meeus, 1997 7171 90,990,9 100100 100100 98,398,3
AFP (AFP (AphaApha FetoFeto‐‐ProteinProtein))
‐‐ KishidaKishida 19951995 103103 100100 97 497 4 92 592 5 100100
15
‐‐ KishidaKishida, 1995, 1995 103103 100100 97,497,4 92,592,5 100100
‐‐ Gaucherand, 1995Gaucherand, 1995 131131 8888 8484 8686 8787
Others : hCG, Prolactin, urea, creatinin, lactates …Others : hCG, Prolactin, urea, creatinin, lactates …
amniotic fluid/serum ratio lowamniotic fluid/serum ratio low
FIBRONECTINEFIBRONECTINE
NbNb SensSens SpecSpec VPPVPP VPNVPN
FibronectineFibronectine
‐‐Gaucherand, 1995Gaucherand, 1995‐‐Rutanen, 1993Rutanen, 1993
1311315454
94949292
97978080
97977979
9494‐‐
16
Extracellular matrix protein of membranes > AFExtracellular matrix protein of membranes > AFReleased in the case of preterm labor or labor with intact membranesReleased in the case of preterm labor or labor with intact membranes
Protein present in seminal fluidProtein present in seminal fluidamniotic fluid/serum ratio lowamniotic fluid/serum ratio low
Guibourdenche J et al. Ann Clin Biochem 1999
07/03/11
9
NITRAZINE paper testingNITRAZINE paper testingsimple, cheapsimple, cheap
cervical pH= 5cervical pH= 5‐‐66Amniotic fluid : alkalineAmniotic fluid : alkalineDi i k l i iDi i k l i i
NbNb SensSens SpecSpec VPPVPP VPNVPN
NitrazineNitrazine
-- Gaucherand, 1997Gaucherand, 1997 100100 90,790,7 77,277,2 7575 91,791,7-- De Meeus, 1997De Meeus, 1997 7171 81,181,1 83,383,3 52,652,6 96,196,1
Dipstick colorimetricDipstick colorimetric
17
bacterial bacterial vaginosisvaginosiscervicitiscervicitissemen, alkaline urine, semen, alkaline urine, blood, soap and blood, soap and antiseptic solutionsantiseptic solutions
false false positivepositive
IGFBPIGFBP--1 (ActimProm1 (ActimProm®®))insulininsulin--like growth factor binding proteinlike growth factor binding protein--II
PProduced by decidual cells (placental protein)roduced by decidual cells (placental protein)Immunoenzymometric assay for quantitation Immunoenzymometric assay for quantitation Concentrations = 100 to 1000 fold higher than those in serumConcentrations = 100 to 1000 fold higher than those in serumVery low concentration in urine cervical mucus and seminal fluidVery low concentration in urine cervical mucus and seminal fluid
ActimProm ActimProm –– IGFBPIGFBP--11 NbNb SensSens SpecSpec VPPVPP VPNVPN
Lockwood et al. 1994Lockwood et al. 1994 105105 74,474,4 92,692,6 96,796,7 55,655,6Rutanen et al. 1996Rutanen et al. 1996 130130 100100 94,794,7 93,293,2 100100Gaucherand et al. 1997Gaucherand et al. 1997 100100 95,395,3 98,298,2 97,697,6 96,596,5Marcellin et al 2011Marcellin et al 2011 9090 95 395 3 95 695 6 97 797 7 93 693 6
Very low concentration in urine, cervical mucus and seminal fluidVery low concentration in urine, cervical mucus and seminal fluidRapid strip test (5 min) = > 95th percentile of serum levelsRapid strip test (5 min) = > 95th percentile of serum levels
18
Marcellin et al. 2011Marcellin et al. 2011 9090 95,395,3 95,695,6 97,797,7 93,693,6
07/03/11
10
PAMGPAMG--1 (1 (AmniSureAmniSure®®))
placental alphaplacental alpha--microglobulinmicroglobulin--11PProduced by decidual cells (placental protein)roduced by decidual cells (placental protein)Concentrations = 1 000 to 10 000 fold higher than Concentrations = 1 000 to 10 000 fold higher than those in those in cervical mucuscervical mucus
19
Amnisure Amnisure –– PAMGPAMG--11 NbNb SensSens SpecSpec VPPVPP VPNVPN
Cousin et al . 2005 Cousin et al . 2005 203203 98,998,9 100100 100100 99,199,1
Marcellin et al. 2011Marcellin et al. 2011 9090 92,892,8 91,691,6 90,790,7 93,693,6
Prognosis in case of PPROMPrognosis in case of PPROM
Prognosis of what ?Prognosis of what ?
Preterm Preterm birthbirth
InfectionInfectionNeonatal ?Neonatal ?Maternal ?Maternal ?
20
Neonatal outcome ?Neonatal outcome ?Long term outcome ?Long term outcome ?
07/03/11
11
Intra uterine inflammation or infectionIntra uterine inflammation or infection
21
Clinical chorioamnionitis:Clinical chorioamnionitis:Admission : 1Admission : 1--2 %2 %Subsequently: 3Subsequently: 3--8 %8 %
Positive culture by Positive culture by amniocentesis: 25amniocentesis: 25--40 %40 %
Neonatal infection Neonatal infection 55--10%10%
Natural history of PPROMNatural history of PPROM((SavitzSavitz et al, Am J et al, Am J ObstetObstet GynecolGynecol 1997 et Johnson, 1997 et Johnson, ObstetObstet GynecolGynecol 1981)1981)
100
30405060708090
100 delivery < 7 dy delivery < 48 h
22
01020
24-28 weeks 29-32 weeks 33-36 weeks
07/03/11
12
Relationship between PROM and infectionRelationship between PROM and infectioncause and consequencecause and consequence
maternomaterno fetalfetal
ChorioChorio--decidual decidual Infection or Infection or
inflammationinflammation Non Non infectiousinfectious
intraintra--amniotic amniotic Infection or Infection or
inflammationinflammationPPROMPPROM
maternomaterno--fetalfetalinfection and infection and
deliverydelivery
causescauses
1/2 ?1/2 ?
1/2 ?1/2 ?
23
BacteriaBacteria fromfromcervicocervico--vaginal vaginal
tractustractus
DeliveryDelivery withoutwithoutinfectioninfection
Most WomenMost WomenProportion ?Proportion ?
Best way : diagnosis of inflammation or infection Best way : diagnosis of inflammation or infection in amniotic fluid (amniocentesis)in amniotic fluid (amniocentesis)
•• Culture could be the gold standard for the diagnosis ofCulture could be the gold standard for the diagnosis of•• Culture could be the gold standard for the diagnosis of Culture could be the gold standard for the diagnosis of infectioninfection–– Direct diagnosis of the inflammation or the infectionDirect diagnosis of the inflammation or the infection–– Identification of the germaIdentification of the germa
•• Many short term tests studiedMany short term tests studied
24
–– Gram stain, white blood cell count, leucocyte Gram stain, white blood cell count, leucocyte esterase, glucose concentrationesterase, glucose concentration
–– Interleukines, metalloproteinaseInterleukines, metalloproteinase–– Etc etcEtc etc
07/03/11
13
Disadvantages of amniocentesisDisadvantages of amniocentesis
•• Disadvantages of the procedureDisadvantages of the procedure–– Results of the culture (48 hours) after the delivery frequentlyResults of the culture (48 hours) after the delivery frequently–– Short term test : low specificity and meaning ?Short term test : low specificity and meaning ?–– Success of amniocentesis is associated with amount of amniotic fluid Success of amniocentesis is associated with amount of amniotic fluid
remaining (oligohydramnios in PPROM)remaining (oligohydramnios in PPROM)–– Complications associated with amniocentesis ?Complications associated with amniocentesis ?
•• No evaluation of the use of test No evaluation of the use of test
25
–– Decision ? : antibiotics, Cesarean section, corticosteroid before Decision ? : antibiotics, Cesarean section, corticosteroid before extractionextraction
•• Few team published (many, many) papers on the diagnostic Few team published (many, many) papers on the diagnostic value of theses tests, many methodological weaknesses value of theses tests, many methodological weaknesses
Cytokines in serum or vaginal secretions ?Cytokines in serum or vaginal secretions ?
•• Parturition: ILParturition: IL--6, TNF6, TNFαα, IL, IL--11ββ, IL, IL--88
•• Glycoproteins involved in inflammationGlycoproteins involved in inflammationl d i l ft ti ti f hl d i l ft ti ti f h–– released mainly after activation of macrophagesreleased mainly after activation of macrophages
–– result in the production of prostaglandins and proteases (MMP)result in the production of prostaglandins and proteases (MMP)–– measurement difficult and costly (ELISA in most studiesmeasurement difficult and costly (ELISA in most studies))
•• Prospective study (73 women with PPROM) (Kayem et al 2005)Prospective study (73 women with PPROM) (Kayem et al 2005)–– diagnostic value of ILdiagnostic value of IL--6 in vaginal secretions for neonatal infection in cases of 6 in vaginal secretions for neonatal infection in cases of
PPROMPPROM–– Immunochromatographic bed side test (20 minutes)Immunochromatographic bed side test (20 minutes)
26
IL-6control
07/03/11
14
Odds of neonatal infection as function of maternalOdds of neonatal infection as function of maternalmarkers, based on logistic regressionmarkers, based on logistic regression
Congenital proven or probable
Without
congenital sepsis
OR
Adjusted OR
probable sepsis n =16
sepsis
n = 68
Vaginal IL6 positive
12 (75.0)
29 (42.6)
4.0 (1.3-13)
5.5 (1.2-17.7)
Maternal serum C-Reactive Protein
> 5 mg/dl > 20 mg /dl
9 (52.9) 4 (23 5)
31 (41.3) 5 (7 4)
1.2 (0.5-4.6) 3 4 (1 0 16 5)
5 6 (0 95 32 6)
27
> 20 mg /dl
4 (23.5) 5 (7.4) 3.4 (1.0-16.5) 5.6 (0.95-32.6)
Maternal WBC (x 1000 : ) > 15 > 20
3 (18.9) 1 (6.2)
21 (30.9) 4 (5.9)
0.6 (0.13-1.97)1.0 (0.1-10.2)
ConclusionConclusion•• DiagnosisDiagnosis
–– Clinical Clinical Biomakers necessary in 10Biomakers necessary in 10 20 %20 %–– Biomakers necessary in 10Biomakers necessary in 10--20 %20 %
•• Nitrazine +Nitrazine +-- PROM test or Amnisure testPROM test or Amnisure test•• Perspective : Biomarker sPerspective : Biomarker strictly specific of the AF trictly specific of the AF and and
eeasily detectable at low concentrationasily detectable at low concentration
•• PrognosisPrognosis
28
–– To predict subclinical infection before onset of To predict subclinical infection before onset of labor, butlabor, but
•• Which kind of management ?Which kind of management ?•• No simple biomarkers availableNo simple biomarkers available
Recommended